Literature DB >> 22056902

Mood and anxiety in the medically ill.

Per Bech1.   

Abstract

In this review on rating scales for anxiety and depression, only instruments considered to be quantifiable, analogue to the measurement of hypertension in the medical setting, have been selected. The clinimetric method for validating these rating scales is the item response theory model in which the individual items are rank ordered on the dimensions of anxiety or depression, resulting in their total score being a sufficient statistic. The measurement of anxiety and mood on their respective dimensions of severity implies that we can speak of primary and secondary anxiety or depression in the same way as we speak about primary hypertension (without a medical explanation) and secondary hypertension (when caused be various medical conditions). Both clinician-rated scales and patient-rated questionnaires are discussed. The Clinical Interview for Depression and Related Syndromes (CIDRS) is included in the appendix as this CIDRS covers many of the rating scales measuring mood and anxiety.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22056902     DOI: 10.1159/000330012

Source DB:  PubMed          Journal:  Adv Psychosom Med        ISSN: 0065-3268


  3 in total

1.  Anxiety in the Medically Ill: A Systematic Review of the Literature.

Authors:  Sara Romanazzo; Giovanni Mansueto; Fiammetta Cosci
Journal:  Front Psychiatry       Date:  2022-06-03       Impact factor: 5.435

Review 2.  [Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses : a systematic review].

Authors:  G Nübling; S Allmendinger; S Lorenzl
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

3.  The neuroanatomical correlates of anxiety in a healthy population: differences between the State-Trait Anxiety Inventory and the Hamilton Anxiety Rating Scale.

Authors:  Giulia Donzuso; Antonio Cerasa; Maria C Gioia; Manuela Caracciolo; Aldo Quattrone
Journal:  Brain Behav       Date:  2014-06-18       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.